Dobutamine in paediatric population: a systematic review in juvenile animal models.

<h4>Objective</h4>Although dobutamine is widely used in neonatal clinical practice, the evidence for its use in this specific population is not clear. We conducted a systematic review of the use of dobutamine in juvenile animals to determine whether the evidence from juvenile animal expe...

Full description

Saved in:
Bibliographic Details
Main Authors: Victoria Mielgo, Adolf Valls i Soler, Carmen Rey-Santano
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0095644&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849728267122114560
author Victoria Mielgo
Adolf Valls i Soler
Carmen Rey-Santano
author_facet Victoria Mielgo
Adolf Valls i Soler
Carmen Rey-Santano
author_sort Victoria Mielgo
collection DOAJ
description <h4>Objective</h4>Although dobutamine is widely used in neonatal clinical practice, the evidence for its use in this specific population is not clear. We conducted a systematic review of the use of dobutamine in juvenile animals to determine whether the evidence from juvenile animal experiments with dobutamine supported the design of clinical trials in neonatal/paediatric population.<h4>Methods</h4>Studies were identified by searching MEDLINE (1946-2012) and EMBASE (1974-2012). Articles retrieved were independently reviewed by three authors and only those concerning efficacy and safety of the drug in juvenile animals were included. Only original articles published in English and Spanish were included.<h4>Results</h4>Following our literature search, 265 articles were retrieved and 24 studies were included in the review: 17 focused on neonatal models and 7 on young animal models. Although the aims and design of these studies, as well as the doses and ages analysed, were quite heterogeneous, the majority of authors agree that dobutamine infusion improves cardiac output in a dose dependent manner. Moreover, the cardiovascular effects of dobutamine are influenced by postnatal age, as well as by the dose used and the duration of the therapy. There is inadequate information about the effects of dobutamine on cerebral perfusion to draw conclusions.<h4>Conclusion</h4>There is enough preclinical evidence to ensure that dobutamine improves cardiac output, however to better understand its effects in peripheral organs, such as the brain, more specific and well designed studies are required to provide additional data to support the design of clinical trials in a paediatric population.
format Article
id doaj-art-e6c3bc50566e4a1c85f769403fe6fc63
institution DOAJ
issn 1932-6203
language English
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-e6c3bc50566e4a1c85f769403fe6fc632025-08-20T03:09:35ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9564410.1371/journal.pone.0095644Dobutamine in paediatric population: a systematic review in juvenile animal models.Victoria MielgoAdolf Valls i SolerCarmen Rey-Santano<h4>Objective</h4>Although dobutamine is widely used in neonatal clinical practice, the evidence for its use in this specific population is not clear. We conducted a systematic review of the use of dobutamine in juvenile animals to determine whether the evidence from juvenile animal experiments with dobutamine supported the design of clinical trials in neonatal/paediatric population.<h4>Methods</h4>Studies were identified by searching MEDLINE (1946-2012) and EMBASE (1974-2012). Articles retrieved were independently reviewed by three authors and only those concerning efficacy and safety of the drug in juvenile animals were included. Only original articles published in English and Spanish were included.<h4>Results</h4>Following our literature search, 265 articles were retrieved and 24 studies were included in the review: 17 focused on neonatal models and 7 on young animal models. Although the aims and design of these studies, as well as the doses and ages analysed, were quite heterogeneous, the majority of authors agree that dobutamine infusion improves cardiac output in a dose dependent manner. Moreover, the cardiovascular effects of dobutamine are influenced by postnatal age, as well as by the dose used and the duration of the therapy. There is inadequate information about the effects of dobutamine on cerebral perfusion to draw conclusions.<h4>Conclusion</h4>There is enough preclinical evidence to ensure that dobutamine improves cardiac output, however to better understand its effects in peripheral organs, such as the brain, more specific and well designed studies are required to provide additional data to support the design of clinical trials in a paediatric population.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0095644&type=printable
spellingShingle Victoria Mielgo
Adolf Valls i Soler
Carmen Rey-Santano
Dobutamine in paediatric population: a systematic review in juvenile animal models.
PLoS ONE
title Dobutamine in paediatric population: a systematic review in juvenile animal models.
title_full Dobutamine in paediatric population: a systematic review in juvenile animal models.
title_fullStr Dobutamine in paediatric population: a systematic review in juvenile animal models.
title_full_unstemmed Dobutamine in paediatric population: a systematic review in juvenile animal models.
title_short Dobutamine in paediatric population: a systematic review in juvenile animal models.
title_sort dobutamine in paediatric population a systematic review in juvenile animal models
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0095644&type=printable
work_keys_str_mv AT victoriamielgo dobutamineinpaediatricpopulationasystematicreviewinjuvenileanimalmodels
AT adolfvallsisoler dobutamineinpaediatricpopulationasystematicreviewinjuvenileanimalmodels
AT carmenreysantano dobutamineinpaediatricpopulationasystematicreviewinjuvenileanimalmodels